Poly Medicure profit and loss

Latest FY26

Revenue: ₹1,875cr+12.3% on FY25
EBITDA: ₹442cr−2.3% on FY25
Net profit: ₹321cr−5.3% on FY25
EPS: ₹31.79−6.9% on FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Expenses
	1,997	1,875	1,670	1,376	1,115	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	111	120	89.1	58.7	36.2
	2,109	1,995	1,759	1,435	1,151
	642	599	571	465	424
	6.9	5.1	7.9	7.0	5.2
	−39.7	−7.6	−24.6	10.8	−23.6
	457	402	302	246	203
	21.8	18.3	12.0	11.3	8.8
	128	116	82.6	63.9	57.2
	470	434	361	289	241
	1,686	1,567	1,312	1,093	916
	461	442	453	358	265
	333	327	370	294	208
Profit
	423	429	447	342	236
	−6.8	−6.8	0.0	0.0	0.0
	416	422	447	342	236
	108	101	95.7	77.0	59.3
	1.3	5.3	18.3	9.0	−1.1
	109	107	114	86.0	58.2
	5.9	5.7	5.2	2.5	1.9
	313	321	339	258	179
	307	315	333	256	177
	47.1	46.5	−1.4	−0.9	0.4
	360	367	337	257	180
	315	322	339	258	179
	−2.2	−1.4	0.0	0.0	0.0
Per share
	₹31.09	₹31.79	₹34.13	₹26.92	₹18.69
	₹31.06	₹31.75	₹34.11	₹26.90	₹18.67
Other comprehensive income — detail
	47.1	46.5	−1.4	—	—
	0.6	0.3	−2.1	−1.1	0.2
	0.1	0.1	−0.5	—	—
	—	—	—	−0.3	0.0
	46.7	46.3	0.2	−0.0	0.3
	362	369	337	257	180
	−2.2	−1.4	0.0	0.0	0.0
Per share — as-filed variants
	₹31.09	₹31.79	₹34.13	₹26.92	₹18.69
	₹31.06	₹31.75	₹34.11	₹26.90	₹18.67
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	1,388	1,278	1,115	893	709
	69.5%	68.2%	66.8%	64.9%	63.6%
Adjusted (ex-exceptional items) — derived
	423	429	447	342	236
	−6.8	−6.8	0.0	0.0	0.0
	318	326	339	258	179
	₹31.59	₹32.29	₹34.13	₹26.92	₹18.69

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

POLYMED₹1,446.00

Poly Medicure Ltd.

· Pharma & Health

Annual Quarterly₹ CrorePeersPFIZER RAINBOW ONESOURCE KIMS JUBLPHARMA VIJAYA INDGN GRANULESMcap ₹14,657 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Revenue from Operations	1,115.2	1,375.8	1,669.8	1,875.3	1,997.4
Other Income	36.2	58.7	89.1	120.1	111.4
Total Income	1,151.4	1,434.5	1,759.0	1,995.3	2,108.8
Expenses
+ Cost of Materials Consumed	424.3	464.8	571.4	599.4	642.2
+ Purchases of Stock-in-Trade	5.2	7.0	7.9	5.1	6.9
+ Changes in Inventories	-23.6	10.8	-24.6	-7.6	-39.7
+ Employee Benefit Expense	202.7	245.9	301.5	402.3	457.1
+ Finance Costs	8.8	11.3	12.0	18.3	21.8
+ Depreciation & Amortisation	57.2	63.9	82.6	115.5	128.2
+ Other Expenses	241.2	289.1	360.8	433.9	469.7
Total Expenses	915.9	1,092.8	1,311.6	1,566.8	1,686.1
EBITDA	265.4	358.2	452.8	442.3	461.4
EBIT	208.2	294.3	370.2	326.8	333.2
Profit
PBT before Exceptional Items	235.6	341.7	447.3	428.6	422.7
+ Exceptional Items	0.0	0.0	0.0	-6.8	-6.8
Pretax Income	235.6	341.7	447.3	421.8	415.9
+ Current Tax	59.3	77.0	95.7	101.5	107.6
+ Deferred Tax	-1.1	9.0	18.3	5.3	1.3
Tax Expense	58.2	86.0	114.0	106.7	108.9
+ Share of Associates & JVs	1.9	2.5	5.2	5.7	5.9
Net Income	179.3	258.3	338.6	320.7	312.9
+ Net Income — Continuing Ops	177.4	255.7	333.4	315.0	307.0
+ Other Comprehensive Income	0.4	-0.9	-1.4	46.5	47.1
Total Comprehensive Income	179.7	257.4	337.2	367.2	360.1
Net Income to Common	179.3	258.3	338.6	322.1	315.1
Minority Interest	0.0	0.0	0.0	-1.4	-2.2
Per Share
Basic EPS	18.69	26.92	34.13	31.79	31.09
Diluted EPS	18.67	26.90	34.11	31.75	31.06
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	-1.4	46.5	47.1
+ Items NOT to be Reclassified to P&L	0.2	-1.1	-2.1	0.3	0.6
+ Tax on Items NOT to be Reclassified	—	—	-0.5	0.1	0.1
+ Tax on Items NOT to be Reclassified — alt tag	0.0	-0.3	—	—	—
+ Items to be Reclassified to P&L	0.3	-0.0	0.2	46.3	46.7
Comprehensive Income — Owners of Parent	179.7	257.4	337.2	368.7	362.2
Comprehensive Income — Non-controlling Interests	0.0	0.0	0.0	-1.4	-2.2
Per Share — as-filed variants
Basic EPS — Continuing Operations	18.69	26.92	34.13	31.79	31.09
Diluted EPS — Continuing Operations	18.67	26.90	34.11	31.75	31.06
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	709.4	893.2	1,115.1	1,278.4	1,388.1
Gross Margin %	63.61	64.92	66.78	68.17	69.49
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	235.6	341.7	447.3	428.6	422.7
− Exceptional Items (reconciliation)	0.0	0.0	0.0	-6.8	-6.8
Net Income Adj (tax-effected)	179.3	258.3	338.6	325.8	317.9
EPS Adj	18.69	26.92	34.13	32.29	31.59
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	5.00	5.00	5.00	5.00	5.00
Paid Up Equity Capital	48.0	48.0	50.7	50.7	50.7

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.